Equity Overview
Price & Market Data
Price: $102.0
Daily Change: +$4.55 / 4.46%
Daily Range: $95.10 - $103.7
Market Cap: $4,667,955,832
Daily Volume: 87,661
Performance Metrics
1 Week: -2.99%
1 Month: -3.63%
3 Months: 1.99%
6 Months: 1.99%
1 Year: 1.99%
YTD: 1.99%
Details
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a test that provides longitudinal determination of cancer burden through methylation assessment. The company was incorporated in 2016 and is headquartered in Menlo Park, California.